TAVR Valve Durability: Long-Term Outcomes, Unknowns, and Clinical Decision Making with Dr. Curtiss Stinis and Dr. Andrei Pop

As TAVR expands into younger and lower-risk populations, valve durability has become a central question in structural heart care.In this MurmurMD discussion, Dr. Curtiss Stinis and Dr. Andrei Pop review current understanding of TAVR valve durability, focusing on how clinicians interpret available data and apply it to real-world patient decisions.The conversation highlights key themes from the transcript, including:• How durability data for TAVR has evolved over time• The challenges of comparing surgical and transcatheter valve longevity• Structural valve degeneration and how it is defined and measured• The role of patient age and lifetime management strategy• Imaging and follow-up approaches to monitor valve performance• Valve-in-valve considerations as transcatheter valves age• The importance of long-term data as TAVR indications expandThis discussion provides a practical perspective on how clinicians are thinking about durability today while planning for the future of valve therapy.Chapters:00:00 – Introduction to TAVR durability discussion 00:40 – Why durability matters more in lower-risk patients 01:30 – Current data on TAVR valve performance 02:30 – Defining structural valve degeneration 03:20 – Surgical vs transcatheter durability considerations 04:10 – Imaging and long-term follow-up 05:10 – Valve-in-valve strategy and future planning 06:00 – Patient selection and lifetime valve management 07:00 – Key takeaways from the discussion🔔 Subscribe for more insights from interventional experts and real-world program builders.📱 Download the app: https://apps.apple.com/app/apple-store/id1586692687📺 Follow us on YouTube: https://www.youtube.com/channel/UCfrLYhAhliQ2ZvXinkDCZvA#TAVR #StructuralHeart #ValveDurability #AorticStenosis #HeartTeam #InterventionalCardiology #MurmurMD